SciSparc SPRC
NASDAQ SPRC
$0.38 -0.03 (-7.87%)
As of: Nov 10, 2026 · 12:24 PM EST

SciSparc (SPRC) Current Leases (2021)

Updated

SciSparc (SPRC) reported Current Leases of $341,000 for Q2 2025, compared with $26,000 a year earlier.

Analysis

SciSparc (SPRC) Current Leases (2021) Analysis & Trends

At the end of FY2024, SciSparc posted Current Leases of $9,000, down 62.5% from FY2023.

  • Current Leases has a three-year compound annual growth rate of -20.6% (FY2021 to FY2024).
  • By year, Current Leases came in at $24,000 in FY2023 and $18,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 SciSparc 49,990.67 -14.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 18,000.00
API Access

SciSparc Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=SPRC&period=max&api_key=YOUR_API_KEY